Use of ¹⁸F-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography to successfully diagnose central nervous system vasculitis in systemic lupus erythematosus and antiphospholipid syndrome: a case report

References

• ACR ad hoc committee on neuropsychiatric lupus nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum. 1999;42(4):599–608.
   Google Scholar
• Arkema EV, Svenungsson E, Von Euler M, et al. Stroke in systemic lupus erythematosus: a Swedish population-based cohort study. Ann Rheum Dis. 2017;76(9):1544–1549.
   Web of Science ®Google Scholar
• Hawkins C, Gatenby P, Tuck R, et al. Cerebrovascular disease associated with antiphospholipid antibodies: more questions than answers. J Autoimmune Dis. 2006;3:3.
   Google Scholar
• Gao N, Wang Z, Li M, et al. Clinical characteristics and risk factors of intracranial hemorrhage in systemic lupus erythematosus. Lupus. 2013;22(5):453–460.
   Web of Science ®Google Scholar
• Nikolov NP, Smith JA, Patronas NJ, et al. Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosus. Nat Clin Pract Rheumatol. 2006;2(11):627–633.
   Google Scholar
• Grayson PC, Alehashemi S, Bagheri AA, Civelek AC, et al. 18 F-fluorodeoxyglucose-positron emission tomography as an imaging biomarker in a prospective, longitudinal cohort of patients with large vessel vasculitis. Arthritis Rheumatol. 2018;70(3):439–449.
   PubMed Web of Science ®Google Scholar
• Ramage AE, Fox PT, Brey RL, et al. Neuroimaging evidence of white matter inflammation in newly diagnosed Systemic Lupus Erythematosus. Arthritis Rheum. 2011;63(10):3048–3057.
   Google Scholar
• Burghaus L, Kabbasch C, Deckert M, et al. FET PET in primary central nervous system vasculitis. Clin Nucl Med. 2018;43(9):e322–e323.
   PubMed Web of Science ®Google Scholar
• Giannitti C, Cerase A, Miracco C, et al. Cerebral haemorrhage in a patient with systemic lupus erythematosus and vasculitis treated with intravenous immunoglobulins for a longtime and in absence of other risk factors. Clin Ter. 2011;162(2):125–127.
   Web of Science ®Google Scholar
• Li J, Pan Z, Liu H, et al. Retrospective analysis of the risk of hemorrhage associated with moderate and severe thrombocytopenia of 173 patients with systemic lupus erythematosus. Medicine. 2018;97(27):e11356.
   Web of Science ®Google Scholar
• Barile-Fabris L, Hernández-Cabrera MF, Barragan-Garfias JA. Vasculitis in systemic lupus erythematosus. Curr Rheumatol Rep. 2014;16(9):440.
   PubMed Web of Science ®Google Scholar
• Rowshani AT, Remans P, Rozemuller A, Tak PP. Cerebral vasculitis as a primary manifestation of systemic lupus erythematosus. Ann Rheum Dis. 2005;64(5):784–786.
   Web of Science ®Google Scholar
• Jennekens FGI, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (Oxford). 2002;41(6):619–630.
   PubMed Web of Science ®Google Scholar
• Quintero M, Mirza N, Chang H, et al. Antiphospholipid antibody syndrome associated with primary angiitis of the central nervous system: report of two biopsy proven cases. Ann Rheum Dis. 2006;65(3):408–409.
   Web of Science ®Google Scholar
• Bertsias GK, Ioannidis JPA, Aringer M, et al. EULAR recommendations for the management of systemic lupus erythematosus with neuropsychiatric manifestations: Report of a task force of the EULAR standing committee for clinical affairs. Ann Rheum Dis. 2010;69(12):2074–2082.
   PubMed Web of Science ®Google Scholar
• Hirohata S, Kanai Y, Mitsuo A, et al. Accuracy of cerebrospinal fluid IL-6 testing for diagnosis of lupus psychosis. A multicenter retrospective study. Clin Rheumatol. 2009;28(11):1319–1323.
   PubMed Web of Science ®Google Scholar
• Asano T, Ito H, Kariya Y, et al. Evaluation of blood-brain barrier function by quotient alpha2 macroglobulin and its relationship with interleukin-6 and complement component 3 levels in neuropsychiatric systemic lupus erythematosus. PLoS One. 2017;12(10):e0186414.
   PubMed Web of Science ®Google Scholar
• Vlachogiannis P, Hillered L, Khalil F, et al. Interleukin-6 levels in cerebrospinal fluid and plasma in patients with severe spontaneous subarachnoid hemorrhage. World Neurosurg. 2019;122:e612–e618.
   Web of Science ®Google Scholar
• Vila N, Castillo J, Dávalos A, et al. Proinflammatory cytokines and early neurological worsening in ischemic stroke. Stroke. 2000;31(10):2325–2329.
   PubMed Web of Science ®Google Scholar
• Mathiesen T, Andersson B, Loftenius A, et al. Increased interleukin-6 levels in cerebrospinal fluid following subarachnoid hemorrhage. J Neurosurg. 1993;78(4):562–567.
   Web of Science ®Google Scholar
• Tarkowski E, Rosengren L, Blomstrand C, et al. Early intrathecal production of interleukin-6 predicts the size of brain lesion in stroke. Stroke. 1995;26(8):1393–1398.
   PubMed Web of Science ®Google Scholar
• Danve A, O’Dell J. The role of 18F fluorodeoxyglucose positron emission tomography scanning in the diagnosis and management of systemic vasculitis. Int J Rheum Dis. 2015;18(7):714–724.
   Web of Science ®Google Scholar
• Buchsbaum MS, Buchsbaum BR, Hazlett EA, et al. Relative glucose metabolic rate higher in white matter in patients with schizophrenia. Am J Psychiatry. 2007;164(7):1072–1081.
   PubMed Web of Science ®Google Scholar
• Fayed N, Modrego PJ. Comparative study of cerebral white matter in autism and attention-deficit/hyperactivity disorder by means of magnetic resonance spectroscopy. Acad Radiol. 2005;12(5):566–569.
   Web of Science ®Google Scholar
• Zazulia AR, Videen TO, Powers WJ. Transient focal increase in perihematomal glucose metabolism after acute human intracerebral hemorrhage. Stroke. 2009;40(5):1638–1643.
   Web of Science ®Google Scholar
• Heiss WD, Huber M, Fink GR, et al. Progressive derangement of periinfarct viable tissue in ischemic stroke. J Cereb Blood Flow Metab. 1992;12(2):193–203.
   PubMed Web of Science ®Google Scholar
• Nasu S, Hata T, Nakajima T, et al. Evaluation of 18F-FDG PET in acute ischemic stroke: assessment of hyper accumulation around the lesion. Kaku Igaku. 2002;39(2):103–110.
   Google Scholar
• Powers WJ. Intracerebral hemorrhage and head trauma: Common effects and common mechanisms of injury. Stroke. 2010;41(10 Suppl):S107–S110.
   Web of Science ®Google Scholar
• Tschoe C, Bushnell CD, Duncan PW, et al. Neuroinflammation after intracerebral hemorrhage and potential therapeutic targets. J Stroke. 2020;22(1):29–46.
   PubMed Web of Science ®Google Scholar
• Bunevicius A, Yuan H, Lin W. The potential roles of 18F-FDG-PET in management of acute stroke patients. Biomed Res Int. 2013;2013:634598.
   Web of Science ®Google Scholar
• Ramirez GA, Maugeri N, Sabbadini MG, et al. Intravascular immunity as a key to systemic vasculitis: a work in progress, gaining momentum. Clin Exp Immunol. 2014;175(2):150–166.
   Web of Science ®Google Scholar
• Bleeker-Rovers CP, Vos FJ, Corstens FH, et al. Imaging of infectious diseases using [18F] fluorodeoxyglucose PET. Q J Nucl Med Mol Imaging. 2008;52(1):17–29.
   Web of Science ®Google Scholar
• Farrah TE, Basu N, Dweck M, et al. Advances in therapies and imaging for systemic vasculitis. Arterioscler Thromb Vasc Biol. 2019;39(8):1520–1541.
   Web of Science ®Google Scholar
• Ben Shimol J, Amital H, Lidar M, et al. The utility of PET/CT in large vessel vasculitis. Sci Rep. 2020;10(1):17709.
   Web of Science ®Google Scholar
• Martínez-Rodríguez I, Jiménez-Alonso M, Quirce R, et al. 18F-FDG PET/CT in the follow-up of large-vessel vasculitis: a study of 37 consecutive patients. Semin Arthritis Rheum. 2018;47(4):530–537.
   Web of Science ®Google Scholar
• Lapointe S, Perry A, Butowski NA. Primary brain tumours in adults. Lancet. 2018;392(10145):432–446.
   PubMed Web of Science ®Google Scholar
• Bae S, An C, Ahn SS, et al. Robust performance of deep learning for distinguishing glioblastoma from single brain metastasis using radiomic features: model development and validation. Sci Rep. 2020;10(1):12110.
   PubMed Web of Science ®Google Scholar
• Focusing on brain tumours and brain metastasis. Nat Rev Cancer. 2020;20(1):1.
   Web of Science ®Google Scholar
• Purandare NC, Puranik A, Shah S, et al. Common malignant brain tumors: can 18F-FDG PET/CT aid in differentiation? Nucl Med Commun. 2017;38(12):1109–1116.
   PubMed Web of Science ®Google Scholar
• Albano D, Bosio G, Bertoli M, et al. 18F-FDG PET/CT in primary brain lymphoma. J Neurooncol. 2018;136(3):577–583.
   PubMed Web of Science ®Google Scholar
• Higashioka K, Yoshida K, Oryoji K, et al. Successful treatment of lupus cerebrovascular disease with mycophenolate mofetil. Intern Med. 2015;54(17):2255–2259.
   Web of Science ®Google Scholar
• Rizos T, Siegelin M, Hähnel S, et al. Fulminant onset of cerebral immunocomplex vasculitis as first manifestation of neuropsychiatric systemic lupus erythematosus (NPSLE). Lupus. 2009;18(4):361–363.
   Web of Science ®Google Scholar
• Joseph FG, Lammie GA, Scolding NJ. CNS lupus: a study of 41 patients. Neurology. 2007;69(7):644–654.
   PubMed Web of Science ®Google Scholar
• Kidwell CS, Wintermark M. Imaging of intracranial haemorrhage. Lancet Neurol. 2008;7(3):256–267.
   Web of Science ®Google Scholar
• Belmont HM, Abramson SB, Lie JT. Pathology and pathogenesis of vascular injury in systemic lupus erythematosus Interactions of inflammatory cells and activated endothelium. Arthritis Rheum. 1996;39(1):9–22.
   Google Scholar